XERIS PHARMACEUTICALS INC

XERS NASDAQ
11.80
-0.39
-3.20%
交易中 10:22 08/22 EDT
开盘
12.19
昨收
12.19
最高
12.19
最低
11.56
成交量
2.79万
成交均量(3M)
19.73万
52周最高
27.98
52周最低
6.85
换手率
0.15%
市值
2.25亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供XERIS PHARMACEUTICALS INC XERS股票价格,XERIS PHARMACEUTICALS INC股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Xeris Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in developing and commercializing injectable and infusible drug formulations. It uses its non-aqueous formulation technology platforms, XeriSol and XeriJect, to develop and commercialize its products. Its formulation technologies allow for the subcutaneous (SC) and intramuscular (IM) delivery of formulations of peptides, proteins, antibodies and small molecules using commercially-available syringes, auto-injectors, multi-dose pens and infusion pumps. The Company is developing its lead product candidate, the Glucagon Rescue Pen, for the treatment of severe hypoglycemia in people with diabetes. It is also developing treatments for post-bariatric hypoglycemia, congenital hyperinsulinism, hypoglycemia-associated autonomic failure and exercise-induced hypoglycemia. Its Glucagon Rescue Pen offers a stable glucagon that is designed to be administered subcutaneously in a simple two-step process.
展开 >

最近浏览

名称
价格
涨跌幅